Table 1.
Demographic Characteristics of the Sample
| Total | Adolescents | Adults | |||
|---|---|---|---|---|---|
| Variable | M(SD)/n(%) | M(SD)/n(%) | M(SD)/n(%) | F/X2 | p |
| Age | 21.70 (8.78) | 15.69 (1.70) | 26.36 (9.22) | 243.97 | <.001 |
| BMI at admission | 20.41 (5.06) | 18.97 (3.96) | 21.54 (5.52) | 29.00 | <.001 |
| Length of Illness | 6.69 (8.06) | 2.26 (1.80) | 10.29 (9.29) | 134.97 | <.001 |
| Female | 406 (94.86) | 178 (95.19) | 228 (94.61) | 0.73 | .79 |
| Race | 5.53 | .35 | |||
| Caucasian | 317 (74.59) | 130 (69.89) | 187 (78.24) | ||
| Asian | 26 (6.12) | 13 (6.99) | 13 (5.44) | ||
| African American | 2 (0.47) | 1 (0.54) | 1 (0.42) | ||
| Native Hawaiian/Pacific Islander | 1 (0.24) | 0 (0.00) | 1 (0.42) | ||
| Native American/Alaskan Native | 3 (0.71) | 1 (0.54) | 2 (0.84) | ||
| Other | 76 (17.88) | 41 (22.04) | 35 (14.64) | ||
| Ethnicity | 2.27 | .13 | |||
| Hispanic | 70 (16.87) | 25 (13.74) | 45 (19.31) | ||
| Non-Hispanic | 345 (83.13) | 157 (86.26) | 188 (80.69) | ||
| Antidepressant Medication | 234 (59.85) | 62 (39.74) | 172 (73.19) | 43.65 | <.001 |
| Atypical Antipsychotics | 69 (17.65) | 20 (12.82) | 49 (20.85) | 4.16 | .04 |
| Mood Stabilizer | 72 (18.41) | 7 (4.49) | 65 (27.66) | 33.51 | <.001 |
| Anxiolytic | 36 (9.21) | 8 (5.12) | 28 (11.91) | 5.17 | .02 |
| ED Diagnosis | 59.89 | <.001 | |||
| Anorexia Nervosa – Restricting | 191 (44.73) | 121 (65.05) | 70 (29.04) | ||
| Anorexia Nervosa – Binge/Purge | 64 (14.99) | 24 (12.90) | 40 (16.60) | ||
| Bulimia Nervosa | 103 (24.12) | 28 (15.05) | 75 (31.12) | ||
| Binge Eating Disorder | 13 (3.04) | 3 (1.61) | 10 (4.15) | ||
| Other Specified Feeding or Eating Disorder | 56 (13.11) | 10 (5.38) | 46 (19.09) | ||
| Met Remission Criteria at Discharge | 110 (33.44) | 50 (33.3) | 60 (33.5) | .001 | .97 |
| Admission EDE-Q Global | 3.58 (1.64) | 3.30 (1.73) | 3.80 (1.53) | 9.79 | .002 |
Note. BMI = body mass index; ED = eating disorder. ED means reflect full-scale scores.